BS03 Interleukin-11: pro-inflammatory, profibrotic and cardiotoxic – a new therapeutic target in hea...
BS03 Interleukin-11: pro-inflammatory, profibrotic and cardiotoxic – a new therapeutic target in heart failure
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group Ltd and British Cardiovascular Society
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group Ltd and British Cardiovascular Society
Subjects
More information
Scope and Contents
Contents
IntroductionFibrosis and inflammation are key pathophysiological factors in heart failure (HF) however no specific therapies exist which target these pathways. The interleukin-11 (IL11) cytokine was initially described as anti-inflammatory, cardioprotective and important for platelet production. However, while recombinant IL11 is used to treat thro...
Alternative Titles
Full title
BS03 Interleukin-11: pro-inflammatory, profibrotic and cardiotoxic – a new therapeutic target in heart failure
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3060456278
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3060456278
Other Identifiers
ISSN
1355-6037
E-ISSN
1468-201X
DOI
10.1136/heartjnl-2024-BCS.231
